4.5 Article

GRIN2B promoter methylation deficits in early-onset schizophrenia and its association with cognitive function

期刊

EPIGENOMICS
卷 11, 期 4, 页码 401-410

出版社

FUTURE MEDICINE LTD
DOI: 10.2217/epi-2018-0127

关键词

cognition; DNA methylation; first-episode psychosis; GRIN2B; LINE-1; schizophrenia

资金

  1. Fundacao de Amparo aPesquisa do Estado de Sao Paulo, Brazil (FAPESP) [2012/05178-0, 2013/08216-2]
  2. Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)
  3. Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)
  4. FAPESP [2012/05178-0, 2013/08216-2, 2012/17626-7, 2015/02948-7, 2016/12195-9/2017/17480-6, 2013/11167-3]
  5. CAPES
  6. CNPq

向作者/读者索取更多资源

Aim: We investigated GRIN1 and GRIN2B promoter methylation in first-episode schizophrenia patients compared with siblings and controls, testing for correlations between DNA methylation, cognitive performance and clinical variables. Materials & methods: Blood-derived DNA from all groups underwent bisulfite conversion and pyrosequencing to determine methylation at CpG sites within the GRIN1 and GRIN2B promoters and results were compared with the measure of global methylation LINE-7.Results: We found hypomethylation among all CpGs analyzed within GRIN2B promoter in patients and greater LINE-1 methylation in patients and siblings. CpG4 was correlated to a measure of intellectual function. Conclusion: Changes in GRIN2B promoter methylation may represent an environmental influence contributing to glutamatergic dysfunction in psychosis and relate to lower cognitive performance in subjects with first-episode schizophrenia.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据